Please Note: This trial is no longer enrolling new participants
Circulating tumor DNA as a predictive biomarker to individualize therapy in patients with stage III non-small cell lung cancer
| Protocol No. | CTO-IUSCC-0722 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Nasser Hanna | Treatment Type | Retrospective |
| Age Group | Adult | Phase | NA |
